Mr Md Elias Al-Mamun
Tohoku University Graduate School of Medicine, Sendai (Japan)
Rivaroxaban prevents the development of chronic thromboembolic pulmonary hypertension in mice- Novel beneficial effects of the FXa inhibitor-
Event: ESC Congress 2017
Topic: Treatment of hypertension
Session: What is new in venous thromboembolism?
ESC 365 is supported by
